UXIN
Uxin Ltd
$2.01
-4.74%
$442.2M
No data for this timeframe.
Vol
Market Cap$442.2M
Cap SizeSmall Cap
Inst. Holders11 funds
Inst. Value$6.3M
Inst. Activity1 buys / 0 sells
SEC Reports3
Recent Activity
Jun 2, 2026
SEC
Uxin entered a joint venture agreement with Hebei Chengying (a Shijiazhuang state-owned enterprise) to establish a new u
6-K — Impact 4/10
May 14, 2026
Insider
Liu Erhai acquired 558,725,100 shares
Director
Apr 13, 2026
SEC
Uxin Limited announced the appointment of Mr. Wenbing Jing as President, effective April 13, 2026. Jing previously serve
6-K — Impact 3/10
Apr 10, 2026
SEC
Uxin reported strong unaudited financial results for Q4 and full year 2025, with full-year retail transaction volume up
6-K — Impact 8/10
Inst.
MORGAN STANLEY — DOUBLED
150,808 shares ($463.0K)
Inst.
MORGAN STANLEY — DOUBLED
68,353 shares ($230.3K)
Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$4.55 (Dec 2025)
Current $2.01
Low $4.55
Median $4.55
High $4.55
1 analysts
$4.55
$4.55
Analyst Ratings
2Strong Buy
4Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Dec 22, 2025 | Deutsche Bank | INITIATE | Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $-1.17 | $-1.17 — $-1.17 | -710% YoY | 1 |
| Next FY | $-0.34 ▲ +49.8% | $-0.68 — $-0.00 | 71% YoY | 2 |
Latest Reports
NEUTRAL
6-K
4/10
Uxin entered a joint venture agreement with Hebei Chengying (a Shijiazhuang state-owned enterprise) to establish a new u
Jun 2, 2026
NEUTRAL
6-K
3/10
Uxin Limited announced the appointment of Mr. Wenbing Jing as President, effective April 13, 2026. Jing previously serve
Apr 13, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BARCLAYS PLC | $5.2M | DOUBLED |
| MORGAN STANLEY | $463.0K | DOUBLED |
| STATE STREET CORP | $199.2K | — |
| Invesco Ltd. | $103.7K | — |
| Point72 Asset Management, L.P. | $97.8K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 14, 2026 | Liu Erhai | J | $0.00 |
11 institutional holders with $6.3M total value (2,050,923 shares) as of 2026-Q1. Top holders: BARCLAYS, MORGAN, STATE. Net buying activity: 1 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BARCLAYS PLC | 1,706,500 | $5.2M | 83.2% | DOUBLED +185.7% |
| 2 | MORGAN STANLEY | 150,808 | $463.0K | 7.4% | DOUBLED +120.6% |
| 3 | STATE STREET CORP | 64,902 | $199.2K | 3.2% | — |
| 4 | Invesco Ltd. | 33,793 | $103.7K | 1.6% | — |
| 5 | Point72 Asset Management, L.P. | 31,852 | $97.8K | 1.6% | — |
| 6 | GOLDMAN SACHS GROUP INC | 28,633 | $87.9K | 1.4% | — |
| 7 | NOMURA HOLDINGS INC | 17,586 | $54.0K | 0.9% | — |
| 8 | Centiva Capital, LP | 12,537 | $38.5K | 0.6% | — |
| 9 | CITIGROUP INC | 3,900 | $12.0K | 0.2% | — |
| 10 | RHUMBLINE ADVISERS | 378 | $1.2K | 0.0% | ADD +64.7% |
| 11 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 34 | $104.00 | 0.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | DOUBLED | 68,353 | 150,808 | +120.6% | $463.0K | 2026-Q1 |
| MORGAN STANLEY | DOUBLED | 4,084 | 68,353 | +1573.7% | $230.3K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 57 | 166 | +191.2% | $559.00 | 2025-Q4 |
| BARCLAYS PLC | DOUBLED | 248,261 | 709,256 | +185.7% | $2.5M | 2025-Q3 |
| UBS Group AG | DOUBLED | 1,779 | 14,607 | +721.1% | $50.5K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 9,424 | 4,084 | -56.7% | $14.1K | 2025-Q3 |
| RHUMBLINE ADVISERS | ADD | 278 | 458 | +64.7% | $1.6K | 2025-Q3 |
| BANK OF AMERICA CORP /DE/ | TRIM | 215 | 57 | -73.5% | $197.00 | 2025-Q3 |
| UBS Group AG | TRIM | 3,571 | 1,779 | -50.2% | $6.3K | 2025-Q2 |
| UBS Group AG | TRIM | 7,023 | 3,571 | -49.2% | $14.1K | 2025-Q1 |
| BANK OF AMERICA CORP /DE/ | TRIM | 1,321 | 438 | -66.8% | $1.7K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 6,695 | 4,104 | -38.7% | $19.0K | 2024-Q4 |
| RHUMBLINE ADVISERS | DOUBLED | 39 | 258 | +561.5% | $1.2K | 2024-Q4 |
| MORGAN STANLEY | ADD | 4,981 | 6,695 | +34.4% | $44.9K | 2024-Q3 |
1 unique insiders with 1 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 14, 2026 | Liu Erhai | Director | J | 558,725,100 | — | — |
3 SEC filing reports analyzed. Sentiment: 1 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 5.0/10.
NEUTRAL
6-K
4/10
Uxin entered a joint venture agreement with Hebei Chengying (a Shijiazhuang state-owned enterprise)
Jun 2, 2026
NEUTRAL
6-K
3/10
Uxin Limited announced the appointment of Mr. Wenbing Jing as President, effective April 13, 2026. J
Apr 13, 2026
BULLISH
6-K
8/10
Uxin reported strong unaudited financial results for Q4 and full year 2025, with full-year retail tr
Apr 10, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Dec 2025): 86% buy across 7 analysts — 2 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Dec 2025. No current recommendation available.
$4.55 mean target (Dec 2025)
$4.55 Low
$4.55 High
| Metric | Value |
|---|---|
| Current Price | $2.01 |
| Target Low | $4.55 |
| Target Mean | $4.55 |
| Target Median | $4.55 |
| Target High | $4.55 |
| # Analysts | 1 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2024-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2025-03-31 |
$-1.17 | $-1.17 | $-1.17 | -710.3% | — | 0↑ 1↓ | $3.3B | 143.2% | 1 |
| Next FY 2026-03-31 |
$-0.34 | $-0.68 | $-0.00 | 70.8% | +49.8% | — | $6.9B | 107.5% | 2 |
1 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Dec 22, 2025 | Deutsche Bank | INITIATE | — | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| May 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Apr 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Mar 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Feb 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% | |
| Jan 1, 2026 | 2 | 4 | 1 | 0 | 0 | 86% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.